financetom
Business
financetom
/
Business
/
ADF Group Aims to Double LAR's Order Backlog by End of 2027
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ADF Group Aims to Double LAR's Order Backlog by End of 2027
Oct 29, 2025 5:53 AM

08:23 AM EDT, 10/29/2025 (MT Newswires) -- ADF Group ( ADFJF ) on Wednesday said it aims to double LAR's order backlog by the end of 2027, up from $104.5 million as of July 31, 2025, citing the economic outlook and plans to leverage expected operational synergies between the two companies.

"To support the anticipated growth, substantial investments will need to be made at LAR's fabrication plant located in Metabetchouan, in the Saguenay-Lac Saint-Jean region, Quebec," said the company in a statement. "With its extensive experience and recognized for its operational excellence, LAR will benefit from these investments, which should generate operational efficiencies that reflect ADF's approach to maintaining leadership in fabrication equipment and work methods."

ADF and LAR plan to increase the fabrication capacity and modernize the equipment. The company plans to invest over $35 million at LAR's main plant in Saguenay-Lac Saint-Jean over the next two years.

Construction of new buildings is expected to begin in April 2026 in order to be able to receive new equipment by December 2026.

"As previously mentioned, we are convinced that this transaction will create significant synergies between ADF and LAR and will have a positive contribution to ADF's net results, and will diversify ADF's offer where U.S. tariffs threats are concern, while, maintaining 200 well-paying jobs in the greater Saguenay-Lac Saint-Jean region, and even growing this number," said ADF group chief executive Jean Paschini.

A conference call with investors will be held on Oct. 29, at 10 a.m. (Montreal time) to discuss the acquisition of LAR Group.

Shares of the company closed up 1.1% to $7.32 on Tuesday on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Preview: Ul Solutions Inc. Set To IPO Tomorrow
Preview: Ul Solutions Inc. Set To IPO Tomorrow
Apr 11, 2024
UL Solutions Inc. (NYSE:ULS) IPO will take place April, 12 on the NYSE exchange under the ticker ULS. The company is offering shares at an expected price between $26.00 and $29.00 per share with an insider lock-up period of 180 days ending on October 09, 2024. See also: Benzinga IPO Calendar About UL Solutions Inc. UL Solutions Inc is a...
Market Chatter: Clearlake Capital Looking Into Renewed Bid for Blackbaud
Market Chatter: Clearlake Capital Looking Into Renewed Bid for Blackbaud
Apr 11, 2024
11:30 AM EDT, 04/11/2024 (MT Newswires) -- Clearlake Capital is exploring a fresh offer to acquire Blackbaud ( BLKB ) , Bloomberg reported Thursday, citing people with knowledge of the matter. Blackbaud ( BLKB ) rejected Clearlake's previous unsolicited offer in 2023. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from...
Rocket Lab USA Wins $32 Million Contract to Build, Launch Spacecraft for US Space Force's Mission
Rocket Lab USA Wins $32 Million Contract to Build, Launch Spacecraft for US Space Force's Mission
Apr 11, 2024
11:27 AM EDT, 04/11/2024 (MT Newswires) -- Rocket Lab USA ( RKLB ) said Thursday it won a $32 million contract from the US Space Force Space Systems Command to manufacture and launch a spacecraft for the Victus Haze Tactically Responsive Space mission. The Space Force's mission, expected to launch in 2025, will be an exercise of responding to on-orbit...
Kane Biotech Agrees to Sell its Interest in STEM Animal Health for US$8 Million
Kane Biotech Agrees to Sell its Interest in STEM Animal Health for US$8 Million
Apr 11, 2024
11:30 AM EDT, 04/11/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it reached an agreement in principle to sell its entire interest in its STEM Animal Health unit to a third party multi-national pharmaceutical company on a cash-free, debt-free basis for US$8 million. The company said it expected that the sale of STEM Animal Health Kane...
Copyright 2023-2026 - www.financetom.com All Rights Reserved